[Federal Register Volume 74, Number 230 (Wednesday, December 2, 2009)]
[Notices]
[Pages 63157-63158]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-28823]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated September 17, 2009, and published in the Federal 
Register on September 24, 2009, (74 FR 48780), Fisher Clinical 
Services, Inc., 7554 Schantz Road, Allentown, Pennsylvania 18106, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Noroxymorphone (9668), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
analytical research and clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Fisher Clinical Services, Inc., to import the basic 
class of controlled substance is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or

[[Page 63158]]

protocols in effect on May 1, 1971, at this time. DEA has investigated 
Fisher Clinical Services, Inc., to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 
1301.34, the above named company is granted registration as an importer 
of the basic class of controlled substance listed.

     Dated: November 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-28823 Filed 12-1-09; 8:45 am]
BILLING CODE 4410-09-P